FTA To Benefit EU Innovative Drugmakers

BMI View: The free trade agreement between the EU and India provides opportunities for drugmakers to target this high growth market. Furthermore, India's efforts to improve intellectual property legislation, including the introduction of a data exclusivity period, will benefit innovative pharmaceutical companies operating in the region.

To read the full article, please choose one of the following options: